Načítá se...

NEBIVOLOL, BUT NOT METOPROLOL, LOWERS BLOOD PRESSURE IN NITRIC OXIDE-SENSITIVE HUMAN HYPERTENSION

Nebivolol, unlike other selective β(1)-receptor blockers, induces vasodilation attributable to increased nitric oxide (NO) bioavailability. The relative contribution of this mechanism to the blood pressure (BP) lowering effects of nebivolol is unclear because it is normally masked by baroreflex buff...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hypertension
Hlavní autoři: Okamoto, Luis E., Gamboa, Alfredo, Shibao, Cyndya, Arnold, Amy C., Choi, Leena, Black, Bonnie K., Raj, Satish R., Robertson, David, Biaggioni, Italo
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4230998/
https://ncbi.nlm.nih.gov/pubmed/25267802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04116
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!